Seattle Cancer Care Alliance (SCCA) is one of few centers in the United States that has experience treating cutaneous lymphoma and specializes in providing novel therapies and clinical studies for this rare disease. Patients are referred to SCCA for our collaborative efforts between research and clinical studies for peripheral (systemic) and cutaneous T-cell lymphomas in general, as well as specific subtypes, bringing focus to this challenging disease.
SCCA's Cutaneous Lymphoma Specialty Clinic is a multidisciplinary clinic that brings together a team of specialists from dermatology, pathology, oncology, and radiation oncology to comprehensively evaluate and treat cutaneous lymphoma. Treatment options depend on the kind of lymphoma, including its location and stage, as well as other factors, such as overall health.
Several types of treatment can be used against skin lymphoma. These are generally divided into treatments directed at the skin and treatments that can affect the whole body (systemic treatments). Sometimes these two types of treatments are used together. In addition, because it is a chronic disease, many patients are treated with multiple therapies in their lifetime.
Many patients live normal lives while being treated for cutaneous lymphoma and some are able to remain in remission for long periods of time. It is important to discuss all of your treatment options as well as their possible side effects with your doctors to help make the decision that best fits your needs.
Initial treatment of skin lymphoma involves treating the skin tumors directly.
Whole-body treatments are systemic treatments that enter the bloodstream and travel throughout the body.
Some lymphomas may not respond well to treatment. When a cancer returns after treatment it is called recurrent or relapsed.